About 300 reports

  • 8.2.1.4 FDA approvals to increase the commercial availability of insulin
  • TANDEM DIABETES CARE, INC.
  • Insulin
  • Animas Corporation
  • Becton Property Group
  • Eli Lilly & Co.
  • Insulet Corporation
  • 8.2.1.4 FDA approvals to increase the commercial availability of insulin
  • TANDEM DIABETES CARE, INC.
  • Insulin
  • Animas Corporation
  • Becton Property Group
  • Eli Lilly & Co.
  • Insulet Corporation
  • Insulin Pumps Outlook
  • Clinical Indications for Insulin Pump Use
  • Insulin
  • World
  • Market Size
  • Animas Corporation
  • Insulet Corporation
  • ONE YEAR (INSULIN PUMP)
  • Market segmentation by product type
  • Insulin
  • Market Size
  • Insulet Corporation
  • Medtronic, Inc.
  • Roche Group
  • Insulin pen
  • Pen brands and models differ from one another in many ways.
  • Insulin
  • Eli Lilly & Co.
  • Medtronic, Inc.
  • Novo Nordisk Group
  • Sanofi S.A.
  • CANADA - INSULIN PUMP & PUMP SUPPLIES BY PROVINCE & COVERAGE
  • CANADA - PUBLIC REIMBURSEMENT DETAILS OF INSULIN PUMP & PUMP SUPPLIES BY PROVINCE
  • Insulin
  • Medical Device
  • Europe
  • Insulet Corporation
  • Medtronic, Inc.
  • Market segmentation by type of insulin
  • Long-acting insulin
  • Insulin
  • Market Size
  • Lilly Endowment Inc.
  • Novo Nordisk Group
  • Sanofi S.A.
  • Insulin Analogue
  • Animal Insulin
  • Insulin
  • China
  • Market Size
  • Eli Lilly & Co.
  • Hangzhou Sanofi Aventis Minsheng Pharmaceutical Co., Ltd
  • 4.5.3 LIXILAN (INSULIN GLARGINE PLUS LIXISENATIDE) - SANOFI
  • DIABETES AND OBESITY THERAPEUTICS MARKET, GLOBAL, ANNUAL REVENUE FORECAST FOR INSULIN
  • Insulin
  • World
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Novo Nordisk Group
  • Insulin Analogue
  • Human Insulin
  • Insulin
  • China
  • Market Size
  • Hangzhou Sanofi Aventis Minsheng Pharmaceutical Co., Ltd
  • Jiangsu Wanbang Biological Pharmaceutical Co., Ltd
  • Insulin: An overview
  • Insulin delivery technologies
  • Insulin
  • Europe
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Oramed Pharmaceuticals Inc.
  • Profiles of Insulin Producers and Major Insulin
  • VII. Insulin PRODUCER DIRECTORY
  • Insulin
  • China
  • Biological Pharmaceutical Co.
  • Eli Lilly & Co.
  • Hangzhou Sanofi Aventis Minsheng Pharmaceutical Co., Ltd
  • 09.1 FAST-ACTING INSULIN
  • 09.2 INTERMEDIATE-ACTING INSULIN
  • Insulin
  • Europe
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Sanofi S.A.

North America led the insulin biosimilars market due to rising demand for insulin in the region.

  • Insulin
  • Asia
  • Europe
  • World
  • Forecast
  • 5. Scope
  • 7. Latest update
  • Insulin
  • United States
  • Supply
  • Fluor Corporation
  • Novo Nordisk Group

Insulin Lispro Protamine / Insulin Lispro – Introduction ##.

  • Insulin
  • Therapy
  • World
  • Demand

Insulin Regular Human / Insulin Isophane Human – Introduction ##.

  • Insulin
  • Therapy
  • World
  • Demand

Insulin Lispro – Introduction ##.

  • Insulin
  • Therapy
  • World
  • Demand

Insulin Degludec – Introduction ##.

  • Insulin
  • Therapy
  • World
  • Demand

Insulin Aspart – Introduction ##.

  • Insulin
  • Therapy
  • World
  • Demand

Insulin Isophane Human – Introduction ##.

  • Insulin
  • Therapy
  • World
  • Demand

Insulin Regular Human – Introduction ##.

  • Insulin
  • Therapy
  • World
  • Demand

Engineering of Synthetic Insulin ##. ## Production of Human Insulin ##. ## Categorization of Insulin & Its Analogues ##. ##. ## Rapid Acting Insulins ##. ##. ## Short Acting Insulins ##. ##. ## Intermediate Insulin ##. ##. ## Long Lasting Insulins ##.

  • Biosimilar
  • Insulin
  • Therapy
  • World
  • Market Size

Insulin - Market Trends & Insights ##.

  • Insulin
  • China
  • India
  • World
  • Market Shares
  • 3.2.4 Toujeo (insulin glargine) - Sanofi
  • 3.3 Short-Acting Insulin Therapies (Bolus Insulins)
  • Insulin
  • World
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Eli Lilly & Co.
  • Insulin Types
  • Benefits and Drawbacks of Insulin Pens
  • Diabetes
  • Insulin
  • Forecast
  • Nipro Corporation
  • Nuova Aptaca SRL
  • Diabetes Care Devices Market Trends and Strategies
  • Data
  • Insulin
  • World
  • Market Size
  • Medtronic, Inc.
  • Roche Group

In 2016, the largest segment in the total insulin market was long-acting insulin.

  • Insulin
  • Therapy
  • United States
  • Market Size

For the purpose of this study, Grand View Research has segmented the global insulin market on the basis of product, segment (on the basis of source), application and region: - Insulin Product Outlook - Fast Acting Insulin - Short Acting Insulin - Intermediate Acti

  • Insulin
  • Therapy
  • World
  • Forecast

The launch of the biosimilar insulin Basaglar is a threat to the insulin-based product market, which includes long-time reference product Lantus as well as newer entrants Toujeo and Tresiba.

  • Biopharmaceutical
  • Biosimilar
  • Insulin
  • Europe
  • Market Description